Delivery Order SPE2DE21D7010-SPE2D626F15S8
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 28, 2025, with an ultimate completion date of January 5, 2026. This fixed-price delivery order with economic price adjustment mechanism is for MAXCESS spinal surgical products and related medical technologies. The award was issued under an open market competitive procurement with no set-aside designation, reflecting...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 on December 11, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with economic price adjustment mechanisms, is scheduled for completion by January 2, 2026. This award was issued without set-aside restrictions, indicating competitive open market procurement. Nuvasive...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $8,427 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 3, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment pricing and involves no set-aside designation, indicating open market competition. The award covers SIMPLIFY spinal surgery products...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $4,346 fixed-price delivery order with economic price adjustment (FPEA) by the Defense Logistics Agency (DLA) Medical Supply Chain on November 26, 2025, with a completion date of January 5, 2026. This delivery order, issued without set-aside designation, represents a competitive open-market procurement for specialized spinal surgical products and services to support...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $5,204.05 on November 14, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is for the supply of LEVERAGE LFS spinal medical devices and related surgical instruments, with performance to be completed by December 5, 2025, at Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $43,480.80 fixed-price delivery order with economic price adjustment provisions by the Defense Logistics Agency Medical Supply Chain on October 28, 2025, with an ultimate completion date of November 18, 2025. The award is designated as an M5 delivery order issued without set-aside restrictions, indicating competition in an open market procurement. Performance will be...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., received a $12,969.84 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency Medical Supply Chain on December 11, 2025, with an ultimate completion date of December 12, 2025. The delivery order, designated as MODULUS, represents procurement of specialized spinal surgical products and medical devices for Department of Defense and Department of Veterans...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and services, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on May 8, 2025. This fixed-price delivery order with economic price adjustment mechanism carries an ultimate completion date of May 9, 2025, and is not associated with any set-aside designation, indicating open market competition. The contract supports the federal healthcare system's...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F15S8Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 26, 2025, for the MAXCESS spinal surgical product line. The contract, which is structured as a fixed-price agreement with economic price adjustment provisions, carries an ultimate completion date of January 5, 2026, and will be performed at Nuvasive's San Diego, California facility. This delivery order was issued without set-aside designation, reflecting Nuvasive's successful competition in open market federal procurements. This award represents a task order issued under the Defense Health Agency's $8 million Indefinite Delivery/Indefinite Quantity Blanket Purchase Agreement with Transplant Technology Inc., effective through March 2027, which streamlines procurement of Nuvasive's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and biologics across Department of Defense and Department of Veterans Affairs medical facilities. Nuvasive serves as a critical supplier to federal healthcare agencies, providing specialized spinal surgery technologies and bone graft materials that support advanced orthopedic and neurosurgical procedures for military personnel and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/25/25 |